NSE filing, NSE: AYE. Summary written from the filing by ALFA Finder's alert engine.
Aye Finance Ltd: key numbers
- Share price
- ₹133.20
- Market cap
- ₹3,288 Cr
- Revenue (annual)
- ₹1,815 Cr
- Net profit (annual)
- ₹193.6 Cr
- P/E (TTM)
- 11.3×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 18.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aye Finance Ltd
All →Aye Finance Other Announcement
Aye Finance filed a Crisil monitoring report on IPO proceeds for the quarter ended September 2026. It reports no deviation from objects, a routine compliance filing.
Aye Finance Earnings Call Transcript: Key Takeaways
Aye Finance delivered a robust Q2 with AUM growing 26% YoY, driven by improved productivity and lower credit costs. Profits more than doubled as operating leverage and reduced borrowing costs kicked in.
- Call
- Guides 30% growth
Aye Finance Investor Presentation: Key Takeaways
Aye Finance reported robust Q2FY27 results with 24% YoY revenue growth and 151% YoY PAT growth, driven by improved operational efficiency and expanding customer franchise to 6.9 lakh borrowers.
Aye Finance Results Update
Aye Finance reported record quarterly PAT of ₹86.7 Crore in Q2FY27, up 151% YoY. AUM grew to ₹7,597 Crore with credit costs falling to 3.8%.
Aye Finance Q2 FY27 Results: Net Profit ₹86.7 Cr, Up 151.3% YoY
Aye Finance Ltd reported revenue from operations of ₹514.4 Cr (+18.3% YoY) and net profit of ₹86.7 Cr (+151.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹86.7 Cr · +151.3% YoY
Aye Finance Debt & Borrowing: ₹0.99 Cr
Aye Finance has fulfilled its interest payment obligations for two series of listed NCDs, totaling ₹0.99 Crore. Payments were made on October 19, 2026.
- Value
- ₹0.99 Cr
Other employee stock options announcements
All →Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date
V-Guard Industries Employee Stock Options
V-Guard's committee approved a grant of 16,747 ESOS 2013 options on October 28, 2026. Options vest over up to four years, with a ₹1 exercise price.